Steven Cohen Mersana Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.06 - $3.91 $14,376 - $53,031	13,563 Added 390.08%	17,040 $21,000
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $10,709 - $33,205	3,477 New	3,477 $11,000
Q1 2022 May 16, 2022	SELL	$3.74 - $6.63 $3.06 Million - $5.42 Million	-818,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $4.48 Million - $8.07 Million	818,100 New	818,100 $5.09 Million
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $230,264 - $389,243	-26,900 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$13.28 - $18.07 $13.5 Million - $18.4 Million	-1,016,200 Reduced 97.42%	26,900 $365,000
Q1 2021 May 17, 2021	BUY	$15.31 - $26.52 $1.85 Million - $3.21 Million	121,100 Added 13.13%	1,043,100 $16.9 Million
Q4 2020 Feb 16, 2021	SELL	$16.84 - $27.59 $2.05 Million - $3.36 Million	-121,933 Reduced 11.68%	922,000 $24.5 Million
Q3 2020 Nov 16, 2020	BUY	$16.2 - $25.7 $16.9 Million - $26.8 Million	1,043,933 New	1,043,933 $19.4 Million
Q1 2020 May 15, 2020	SELL	$4.41 - $9.28 $661,500 - $1.39 Million	-150,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.45 - $6.73 $500,250 - $2.32 Million	-345,000 Reduced 69.7%	150,000 $860,000
Q3 2019 Nov 15, 2019	SELL	$1.54 - $4.2 $261,800 - $714,000	-170,000 Reduced 25.56%	495,000 $782,000
Q2 2019 Aug 14, 2019	SELL	$3.84 - $6.4 $3.34 Million - $5.56 Million	-869,370 Reduced 56.66%	665,000 $2.69 Million
Q1 2019 May 15, 2019	BUY	$3.51 - $7.3 $3.46 Million - $7.19 Million	984,370 Added 178.98%	1,534,370 $8.07 Million
Q4 2018 Feb 14, 2019	BUY	$3.45 - $9.72 $1.9 Million - $5.35 Million	550,000 New	550,000 $2.24 Million
Q3 2018 Nov 14, 2018	SELL	$10.0 - $19.02 $1.42 Million - $2.7 Million	-141,808 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$14.2 - $22.68 $400,326 - $639,394	-28,192 Reduced 16.58%	141,808 $2.53 Million
Q1 2018 May 15, 2018	BUY	$13.56 - $18.48 $2.31 Million - $3.14 Million	170,000 New	170,000 $2.68 Million

Others Institutions Holding MRSN

# of Institutions

126

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $55.4M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account